$ Value
$0
Shares
11,755
Price
$0
Filed
Mar 12
Insider
Name
Shibutani Hiroshi Chris
Title
EVP, Chief Strategy Officer
CIK
0002072494
Roles
Transaction Details
Transaction Date
2026-03-10
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
11,755
Footnotes
Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout. | These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board. | Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board.
Filing Info
Shibutani Hiroshi Chris's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-10 | BMY | A | $0 |
| 2026-03-10 | BMY | A | $0 |
| 2025-07-01 | BMY | A | $0 |
Other Insiders at BMY (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| YALE PHYLLIS R | — | — | 2026-03-31 |
| Arduini Peter J | — | — | 2026-03-31 |
| Rice Derica W | — | — | 2026-03-31 |
| Price Paula A | — | — | 2026-02-01 |
| McMullen Michael R. | — | — | 2026-03-31 |
|
Elkins David V
EVP, Chief Financial Officer
|
— | $1.9M | 2026-04-01 |
|
BOERNER CHRISTOPHER S.
Chief Executive Officer
|
— | — | 2026-03-10 |
| Haller Julia A | — | — | 2026-02-01 |
| Samuels Theodore R. II | — | — | 2026-03-31 |
| Vousden Karen H | — | — | 2026-02-01 |
|
Hickey Benjamin
President, RayzeBio Org.
|
— | — | 2026-03-10 |
|
Plenge Robert M
EVP, Chief Research Officer
|
— | — | 2026-03-10 |
| Hidalgo Medina Manuel | — | — | 2026-02-01 |
|
Meyers Gregory Scott
EVP, Chief Digital & Tech Off.
|
— | — | 2026-03-10 |
|
Shanahan Karin
EVP, Chief Supply Chain & Ops
|
— | — | 2026-04-01 |
| Bhatt Deepak | — | — | 2026-02-01 |
|
Lenkowsky Adam
EVP, Chief Commercial Officer
|
— | — | 2026-03-10 |
|
Gallman Cari
EVP, General Counsel
|
— | — | 2026-03-10 |
|
Poole Ahn Amanda
EVP, Chief People Officer
|
— | — | 2026-03-10 |
|
Hoch Lynelle
President, Cell Therapy Org.
|
— | — | 2026-03-10 |
|
Holzer Phil M
SVP and Controller
|
— | — | 2026-03-10 |
|
Short Bartie Wendy
EVP, Corporate Affairs
|
— | — | 2026-03-10 |
|
Shibutani Hiroshi Chris
EVP, Chief Strategy Officer
|
— | — | 2026-03-10 |
|
Massacesi Cristian
EVP,Chief Med Offr,Head of Dev
|
— | — | 2026-03-10 |